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Abstract: 
DNA or RNA aptamers have gained attention as the next generation antibody-like molecules for medical or diagnostic use. 
Conventional secondary structure prediction tools for nucleic acids play an important role to truncate or minimize sequence, or 
introduce limited chemical modifications without compromising or changing its binding affinity to targets in the design of 
improved aptamers selected by Systematic Evolution of Ligands by EXponential enrichment (SELEX). We describe a novel 
software package, ValFold, capable of predicting secondary structures with improved accuracy based on unique aptamer 
characteristics. ValFold predicts not only the canonical Watson-Crick pairs but also G-G pairs derived from G-quadruplex (known 
structure for many aptamers) using the stem candidate selection algorithm. 
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Availability: The software package is freely available through a website.  http://code.google.com/p/valfold/ 
 
 
 
Background: 
Aptamers are well-known nucleic acid molecules that tightly 
bind to their targets by recognizing their three-dimensional 
structures. Aptamers are usually obtained by the SELEX 
(Systematic Evolution of Ligands by EXponential enrichment) 
process [1, 2]. The aptamer sequence data show the following 
four unique characteristics compared to the usual genomic, 
RNA or other natural sequences analysis. The first is that the 
length of each aptamer is usually shorter than 150 bases. The 
second is that the sequence data sets from one selection process 
usually consist of multiple sequence groups. The third unique 
characteristic was that at least two structurally different forms 
are predicted depending on the existence of their targets which 
is well-known in riboswitch studies.  Riboswitches are one of 
the natural aptamers found in micro-organisms and plants [3].  
The fourth is that multiple aptamer sequences usually contain 
some redundant motifs. Experimental truncation approaches of 
aptamers retaining the redundant sequence part could 
sometimes successfully minimize an aptamer length without 
significant loss of its binding activity [4]. It is worthwhile in 
considering the third and the forth characteristics of aptamers 
to verify the strategy of a secondary structure prediction 
algorithm.  The widely-used secondary structure prediction 
software for RNA are well established for the universal 
prediction of RNA molecules, but they have no capability to 
predict the structural changes between the free-form and the 
target molecule-bound form, which, we think, are important 
aspects when the aptamer secondary structure is predicted. 
 
Methodology: 
The ValFold program is developed using Java (JDK 1.6.0).  The 
mainstream of ValFold is a secondary structure prediction 
algorithm to minimize the free energy.  We expand this 
algorithm to predict the G-quartet structure, which is generally 
known as the unique structure of the telomere part of all 
chromosomes [5], and also reported in many aptamers binding 
to target molecules [6]. ValFold algorithm is based on the 
optimization concept for all of the stem candidate 
combinations. It also predicts the G-quartet structure because 
the G-quartet structure candidate list is combined with the stem BIOINFORMATION  open access 
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candidate list at the same time. Each G-quartet structure 
candidate has a report with Gibbs free energy parameter [7]. 
The ValFold algorithm process uses this energy parameter as an 
indicator to find out the G-quartet structure candidates or the 
usual stem candidates. The “CastOff” function is a characteristic 
feature of ValFold.  Aptamers are generally known to bind to 
target molecules on single stranded regions known as “bulge” 
or “loop” [8]. CastOff uses this hypothetical feature in aptamers 
to predict the aptamer binding motif from single sets of SELEX 
sequences. 
 
 
Figure 1: Truncation procedure of ValFold.  Secondary 
structures were drawn by using PseudoViewer [11], Turner 
model  [12] and SantaLucia model [13] are used for the 
calculation of free energies of RNA and DNA aptamers. 
 
The practical process of ValFold algorithm is as follows (Figure 
1A): First, the suboptimal secondary structures among all of the 
sequence sets of SELEX process are predicted by main function 
of ValFold (Step 1). A flowchart of this process is represented in 
Figure 2.  All of the single stranded regions such as “bulge” or 
“loop” candidates are extracted from the suboptimal secondary 
structures, except for the primer compliment sequences (Step 2).  
The maximum length of the motif candidates and the number 
of allowed mismatches in the motif candidates are input for the 
calculation process (Step 3).  Then CastOff algorithm finds the 
conserved scores for each of the motif candidates according to 
the number of the motif conserved sequences.  If one of the 
single stranded region candidates possesses a motif candidate, 
CastOff determines that the sequence is a conserved motif 
candidate (Step 4). A flowchart of these steps 2 to 4 is 
represented in Figure 3.  
 
CastOff determines the highest scoring motif as the most 
possible motif. The filtering of secondary structure candidates 
with CastOff generates results including cases where the motif 
candidates are found only in a bulge and loop structures.   
Therefore, it is possible to select the aptamer secondary 
structures that can bind with the target molecules as a binding 
conformation. If the candidate motif is found on “bulge” or 
“loop” structure on the binding conformation, it is worthwhile 
to attempt to retain those regions in a truncate aptamer 
candidates and subject for further binding assays by 
researchers. The example is shown in Figure 1C. 
 
Software Input and output: 
ValFold supports FASTA format as an input.  Users can add the 
primer region information for each aptamer sequence to use the 
CastOff function.  Calculation results of ValFold are displayed 
with GUI (Figure 1B).  Figure 1B shows the result of a RNA 
aptamer bound to sphingosylphosphorylcholine (SPC) shown 
as an examples [9]. “UUA” was predicted as target binding 
m o t i f  i n  t h e  l o o p  r e g i o n  i n  t h i s  e x a m p l e .   T h e  r e s u l t  w a s  
subsequently validated as the truncated aptamer, m12, is shown 
to bind SPC with good affinity (Figure 1C). 
 
 
Figure 2: Flowchart of ValFold 1 (Figure 1A Step 1). 
 
Caveat and future development: 
We have developed the aptamer truncation program by using a 
binding conformation prediction.  The truncation strategy 
worked very well in some cases such as SPC [9] and rabbit 
immunoglobulin G [10] aptamers which are based on 96 well 
based sequencers.  At this moment, ValFold does not support 
large data sets from next-generation sequencing equipments 
because the current version is computationally slow.  So, we 
need to develop the next version of ValFold to adapt the large 
sequence data sets which will enable us to find better aptamers. 
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Figure 3: Flowchart of ValFold 2 (Figure 1A Step 2, 3, 4). 
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